ArticleBMC cancer2014

Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer.

Jing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.